Movement Alert｜DexCom Intraday Rise 5.27% in Regular Trading, Q3 Beat and Higher Revenue Outlook Lift Shares

Market Focus10-30 22:10

On October 30, DexCom rose 5.27% in Regular Trading, trading near $84.215 per share, with turnover of $167 million.

The move was supported by an earnings-driven catalyst: the company reported third-quarter adjusted EPS of $0.73, above the $0.67 consensus, and revenue of $1.344 billion, ahead of the $1.327 billion expectation. Revenue also increased from $1.21 billion a year earlier.

DexCom also raised its full-year revenue guidance to $5.20 billion-$5.25 billion from the prior $5.18 billion-$5.25 billion range, while Barclays lifted its price target to $120 from $115 after the results, reinforcing the positive read-through from the report.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment